Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial. Gogenur I, Justesen TF, Tarpgaard LS, Bulut M, et al. J Clin Oncol 2026 May 5:JCO2502274. doi: 10.1200/JCO-25-02274.

Read + Share

Amedeo Smart

Independent Medical Education

Gogenur I, Justesen TF, Tarpgaard LS, Bulut M, et al. Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial. J Clin Oncol 2026 May 5:JCO2502274. doi: 10.1200/JCO-25-02274.
PMID: 42085635